We have considered the newest momentous outcomes in carbon-based nanomaterials for utility in controlling and fighting the SARS-CoV-2 virus.
No takes yet. Share an insight, caveat, or question.
Mallakpour et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: